GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytori Cell Research Institute Inc (TSE:3750) » Definitions » Cyclically Adjusted PS Ratio

Cytori Cell Research Institute (TSE:3750) Cyclically Adjusted PS Ratio : 3.25 (As of Jun. 23, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Cytori Cell Research Institute Cyclically Adjusted PS Ratio?

As of today (2024-06-23), Cytori Cell Research Institute's current share price is 円965.00. Cytori Cell Research Institute's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was 円297.21. Cytori Cell Research Institute's Cyclically Adjusted PS Ratio for today is 3.25.

The historical rank and industry rank for Cytori Cell Research Institute's Cyclically Adjusted PS Ratio or its related term are showing as below:

TSE:3750' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.22   Med: 2.96   Max: 3.86
Current: 3.25

During the past years, Cytori Cell Research Institute's highest Cyclically Adjusted PS Ratio was 3.86. The lowest was 0.22. And the median was 2.96.

TSE:3750's Cyclically Adjusted PS Ratio is ranked better than
61.19% of 505 companies
in the Biotechnology industry
Industry Median: 5.25 vs TSE:3750: 3.25

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Cytori Cell Research Institute's adjusted revenue per share data for the three months ended in Dec. 2023 was 円61.498. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is 円297.21 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Cytori Cell Research Institute Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Cytori Cell Research Institute's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytori Cell Research Institute Cyclically Adjusted PS Ratio Chart

Cytori Cell Research Institute Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.39 1.68 3.09 3.23 3.48

Cytori Cell Research Institute Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.62 3.48 3.31 3.90 3.83

Competitive Comparison of Cytori Cell Research Institute's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Cytori Cell Research Institute's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cytori Cell Research Institute's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cytori Cell Research Institute's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cytori Cell Research Institute's Cyclically Adjusted PS Ratio falls into.



Cytori Cell Research Institute Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Cytori Cell Research Institute's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=965.00/297.21
=3.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cytori Cell Research Institute's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Cytori Cell Research Institute's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=61.498/106.8000*106.8000
=61.498

Current CPI (Dec. 2023) = 106.8000.

Cytori Cell Research Institute Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 184.981 95.700 206.436
201406 92.034 98.000 100.298
201409 121.783 98.500 132.045
201412 167.332 97.900 182.544
201503 185.711 97.900 202.594
201506 114.598 98.400 124.381
201509 56.355 98.500 61.104
201512 110.139 98.100 119.907
201603 92.440 97.900 100.844
201606 21.767 98.100 23.697
201609 83.187 98.000 90.657
201612 94.797 98.400 102.889
201703 184.286 98.100 200.629
201706 14.454 98.500 15.672
201709 3.506 98.800 3.790
201712 1.483 99.400 1.593
201803 57.737 99.200 62.160
201806 252.065 99.200 271.376
201809 8.704 99.900 9.305
201812 15.287 99.700 16.376
201903 10.643 99.700 11.401
201906 10.345 99.800 11.071
201909 10.350 100.100 11.043
201912 72.138 100.500 76.660
202003 83.018 100.300 88.398
202006 21.695 99.900 23.193
202009 44.128 99.900 47.176
202012 41.998 99.300 45.170
202103 56.930 99.900 60.862
202106 52.745 99.500 56.615
202109 23.468 100.100 25.039
202112 41.845 100.100 44.646
202203 33.135 101.100 35.003
202206 60.873 101.800 63.863
202209 70.468 103.100 72.997
202212 53.656 104.100 55.048
202303 55.199 104.400 56.468
202306 52.921 105.200 53.726
202309 43.689 106.200 43.936
202312 61.498 106.800 61.498

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cytori Cell Research Institute  (TSE:3750) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Cytori Cell Research Institute Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Cytori Cell Research Institute's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cytori Cell Research Institute (TSE:3750) Business Description

Traded in Other Exchanges
N/A
Address
1-1-1 Otemachi, Otemachi Park Building, Chiyoda-ku, Tokyo, JPN, 100-0004
Cytori Cell Research Institute Inc developing a new clinical approach to cell therapy to provide better medical care to patients by providing medical care that responds to unmet medical needs based on innovative regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.

Cytori Cell Research Institute (TSE:3750) Headlines

No Headlines